Ospedale San Vincenzo

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Melanoma1 trial
• Metastatic breast cancer1 trial

Phase

• Phase 31 trial

Status

• Active, not recruiting2 trials

Lead sponsor

• Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1 trial
• Pierre Fabre Medicament1 trial

Running trials

• Recruiting

  DESTINY Breast Respond HER2-(Ultra)Low Europe

  NCT05945732· Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company· Source

• Active, not recruiting

  Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.

  NCT05270044· Phase 3· Pierre Fabre Medicament· Source